Roche says Phase 3 studies for Alzheimer’s drug failed to meet primary endpoints
November 14, 2022 at 02:13 AM EST
The company said it would keep working on novel diagnostics and treatments for Alzheimer's and said it would present at the Clinical Trials on Alzheimer's Disease Conference.
